185 related articles for article (PubMed ID: 11163508)
1. p53 and Ki-67 as predictive markers for radiosensitivity in squamous cell carcinoma of the oral cavity? an immunohistochemical and clinicopathologic study.
Koelbl O; Rosenwald A; Haberl M; Müller J; Reuther J; Flentje M
Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):147-54. PubMed ID: 11163508
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of Ki-67 (MIB1), PCNA and p53 in cancer of the oropharynx and oral cavity.
Sittel C; Ruiz S; Volling P; Kvasnicka HM; Jungehülsing M; Eckel HE
Oral Oncol; 1999 Nov; 35(6):583-9. PubMed ID: 10705094
[TBL] [Abstract][Full Text] [Related]
3. Markers of radioresistance in squamous cell carcinomas of the head and neck: a clinicopathologic and immunohistochemical study.
Raybaud-Diogène H; Fortin A; Morency R; Roy J; Monteil RA; Têtu B
J Clin Oncol; 1997 Mar; 15(3):1030-8. PubMed ID: 9060543
[TBL] [Abstract][Full Text] [Related]
4. Proliferative index activity in oral squamous cell carcinoma: indication for postoperative radiotherapy?
Gontarz M; Wyszyńska-Pawelec G; Zapała J; Czopek J; Lazar A; Tomaszewska R
Int J Oral Maxillofac Surg; 2014 Oct; 43(10):1189-94. PubMed ID: 24814691
[TBL] [Abstract][Full Text] [Related]
5. Nuclear DNA content, an adjunct to p53 and Ki-67 as a marker of resistance to radiation therapy in oral cavity and pharyngeal squamous cell carcinoma.
Raybaud H; Fortin A; Bairati I; Morency R; Monteil RA; Têtu B
Int J Oral Maxillofac Surg; 2000 Feb; 29(1):36-41. PubMed ID: 10691142
[TBL] [Abstract][Full Text] [Related]
6. Preoperative simultaneous cisplatin- or carboplatin-based chemotherapy and radiotherapy for squamous cell carcinoma of the oral cavity.
Kirita T; Ohgi K; Tsuyuki M; Kamikaido N; Yamamoto K; Sugimura M
J Surg Oncol; 1996 Dec; 63(4):240-8. PubMed ID: 8982368
[TBL] [Abstract][Full Text] [Related]
7. P53 and Ki-67 as outcome predictors for advanced squamous cell cancers of the head and neck treated with chemoradiotherapy.
Lavertu P; Adelstein DJ; Myles J; Secic M
Laryngoscope; 2001 Nov; 111(11 Pt 1):1878-92. PubMed ID: 11801963
[TBL] [Abstract][Full Text] [Related]
8. p53, Cyclin D1, p21 (WAF1) and Ki-67 (MIB1) Expression at Invasive Tumour Fronts of Oral Squamous Cell Carcinomas and Development of Local Recurrence.
Sawair F; Hassona Y; Irwin C; Stephenson M; Hamilton P; Maxwell P; Gordon D; Leonard A; Napier S
Asian Pac J Cancer Prev; 2016; 17(3):1243-9. PubMed ID: 27039754
[TBL] [Abstract][Full Text] [Related]
9. p53 and Ki-67 as markers of radioresistance in head and neck carcinoma.
Couture C; Raybaud-Diogène H; Têtu B; Bairati I; Murry D; Allard J; Fortin A
Cancer; 2002 Feb; 94(3):713-22. PubMed ID: 11857304
[TBL] [Abstract][Full Text] [Related]
10. Outcome and histopathologic regression in oral squamous cell carcinoma after preoperative radiochemotherapy.
Driemel O; Ettl T; Kölbl O; Reichert TE; Dresp BV; Reuther J; Pistner H
Strahlenther Onkol; 2009 May; 185(5):296-302. PubMed ID: 19440668
[TBL] [Abstract][Full Text] [Related]
11. [Neoadjuvant radiochemotherapy for squamous cell carcinoma of the oral cavity].
Bootz F
HNO; 2008 Feb; 56(2):183-4. PubMed ID: 18231725
[No Abstract] [Full Text] [Related]
12. [Predictive and prognostic value of p53, Ki-67 and EGFR in patients with advanced oral cavity and oropharyngeal cancer treated with induction chemotherapy].
Małecki K; Gliński B; Mucha-Małecka A; Roszkowski K; Hetnał M
Przegl Lek; 2012; 69(1):5-8. PubMed ID: 22764511
[TBL] [Abstract][Full Text] [Related]
13. Pre-operative radio-chemotherapy enhances apoptotic cell death in oral squamous cell carcinoma.
Doi R; Makino T; Adachi H; Ryoke K; Ito H
J Oral Pathol Med; 1998 Sep; 27(8):382-7. PubMed ID: 9736427
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant radiochemotherapy and radical resection for advanced squamous cell carcinoma of the oral cavity. Outcome of 134 patients.
Eich HT; Löschcke M; Scheer M; Kocher M; Bongartz R; Wacker S; Zöller JE; Müller RP
Strahlenther Onkol; 2008 Jan; 184(1):23-9. PubMed ID: 18188519
[TBL] [Abstract][Full Text] [Related]
15. Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy.
Gasparini G; Bevilacqua P; Bonoldi E; Testolin A; Galassi A; Verderio P; Boracchi P; Guglielmi RB; Pezzella F
Clin Cancer Res; 1995 Nov; 1(11):1375-83. PubMed ID: 9815934
[TBL] [Abstract][Full Text] [Related]
16. [Preoperative radiochemotherapy of advanced resectable cancer of the oral cavity with cisplatin vs paclitaxel/carboplatin. Analysis of two multimodality treatment concepts].
Eckardt A; Wegener G; Karstens JH
Mund Kiefer Gesichtschir; 2006 Jan; 10(1):30-6. PubMed ID: 16365743
[TBL] [Abstract][Full Text] [Related]
17. [p53 as a biomarker in radiotherapy of carcinoma of the mouth cavity].
Girod SC; Kaupe M; Pfeiffer P; Pape HD
Mund Kiefer Gesichtschir; 1998 Jan; 2(1):11-3. PubMed ID: 9522566
[TBL] [Abstract][Full Text] [Related]
18. An analysis of factors influencing the outcome of postoperative irradiation for squamous cell carcinoma of the oral cavity.
Parsons JT; Mendenhall WM; Stringer SP; Cassisi NJ; Million RR
Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):137-48. PubMed ID: 9300748
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic relevance of proliferation marker Ki-67 (MIB 1), PCNA and p53 in combined surgically and radiologically treated cancers of the oropharynx and mouth cavity].
Sittel C; Ruiz S; Kvasnicka HM; Volling P; Jungehülsing M; Eckel HE
Laryngorhinootologie; 2000 Feb; 79(2):86-92. PubMed ID: 10738715
[TBL] [Abstract][Full Text] [Related]
20. Preoperative radiochemotherapy and radical surgery in comparison with radical surgery alone. A prospective, multicentric, randomized DOSAK study of advanced squamous cell carcinoma of the oral cavity and the oropharynx (a 3-year follow-up).
Mohr C; Bohndorf W; Carstens J; Härle F; Hausamen JE; Hirche H; Kimmig H; Kutzner J; Mühling J; Reuther J
Int J Oral Maxillofac Surg; 1994 Jun; 23(3):140-8. PubMed ID: 7930766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]